5-MeO-DMT vapaa emäs

5-MeO-DMT Freebase – Scientific Product Documentation

General Description

5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) freebase is a naturally occurring tryptamine with a potent psychoactive profile, found in various plants and animal secretions. In its freebase form, it offers superior volatility for certain research methods, making it valuable for pharmacological and neuroscience studies.

Tekniset tiedot

Tieteelliset sovellukset

1. Neuropharmacological Research

• Serotonergic Action:  Potent 5-HT₁ₐ/₂ₐ agonist, relevant for studies of consciousness modulation.

• EEG/fMRI studies:  Investigation of acute effects on brain wave patterns (e.g. gamma oscillations).

• Neuroplasticity:  Possible BDNF-enhancing effects (in animal models).

2. Metabolic & Toxicological Studies

• MAO-dependent metabolism:  Investigation of CYP2D6 and MAO-A degradation pathways.

• Dose-dependent toxicity:  Determination of safety margins in cell cultures.

3. Vertaileva farmakologia

• Compared to DMT:  Higher potency but shorter duration of action (15-30 min when inhaled).

• Compared to psilocybin:  Differences in receptor affinity and subjective effects.

Experimental Guidelines

Recommended Concentrations (In Vitro)

Turvallisuusprotokollat

• Henkilökohtainen suojaus:  Lab coat, nitrile gloves, safety glasses, FFP2 mask when handling powder.

• Ventilation:  Always work under a fume cupboard when heating/evaporating.

• Säilytys:  In amber vials, under argon, at -20°C (long term).

Stability & Storage

• Säilyvyysaika:

  • Room temperature: <24 hours in solution.

  • 4°C: Stable for 3 days (under argon).

  • -20°C: >6 months (unchanged purity).

• Degradation products:

  • Oxidation to indole derivatives (check by TLC/HPLC).

Analytical Certification

Each batch includes:

1. HPLC-UV-kromatogrammi  (λ=280 nm, C18 column)

2. GC-MS confirmation  (characteristic fragments: m/z 174, 160)

3. Jäännösliuotinanalyysi  (≤500 ppm)

4. Water content  (Karl Fischer, <1%)

Oikeudellinen asema (Alankomaat)

• Opium Act:  Not explicitly regulated, but possibly under analogous legislation.

• Lainsäädäntö:  A licence is required for scientific institutions (Appendix 2, Opium Act).

• Vientirajoitukset:  CITES listing (due to natural sources such as  Incilius alvarius ).

Usein kysytyt kysymykset (UKK)

Q1: What is the difference between freebase and fumaric acid salt?
A: Freebase is more volatile (suitable for evaporation experiments), while fumaric acid salt is more stable in solutions.

Q2: How is 5-MeO-DFT detected in toxicology screens?
A: Identifiable by:

• LC-MS/MS (precursor ion m/z 219 → product ion m/z 174)

• Immunoassays: Cross-reactivity with some DMT tests (≤30%).

Q3: Are there any known pharmacokinetic interactions?
A:  Vaaralliset yhdistelmät:

• MAO inhibitors (risk of serotonin syndrome).

• SSRIs (reduced efficacy due to competition).

Q4: How to dispose of waste?
A: Inactivate with:

1. Dilute hydrochloric acid (0.1M) for neutralization.

2. Absorption with activated carbon.

3. Dispose of as  hazardous chemical waste  (UN number: 3249).

References & Contact

Key publications:

• Szára, S. (2007). “DMT and 5-MeO-DMT: Early human studies”.

• Uthaug et al. (2021). “Psychopharmacology of 5-MeO-DMT”.

This product is intended solely for legitimate scientific research. Not for human or veterinary use. Users must comply with all local regulations.